The phosphate carrier protein, mitochondrial (SLC25A3), is a multi-pass transmembrane transporter located in the inner mitochondrial membrane and belongs to the mitochondrial carrier family (SLC25)[1][5][7]. Its principal function is to import inorganic phosphate (Pi) into the mitochondrial matrix, which is essential for ATP production via oxidative phosphorylation[1][5][6]. SLC25A3 is also involved in mitochondrial copper transport, necessary for the activity of cytochrome c oxidase and thus for respiratory chain function[2][3][4]. There are two major isoforms, resulting from alternative splicing, with tissue-specific distribution (cardiac/skeletal muscle vs. ubiquitous)[2][3][5]. Mutations in SLC25A3 cause a severe, often fatal disorder characterized by lactic acidosis, hypotonia, cardiomyopathy, and early death[5][6]. Beyond energy metabolism, SLC25A3 regulates mitochondrial membrane potential, affects susceptibility to cell death via regulation (not direct formation) of the mitochondrial permeability transition pore, and plays a role in mitochondrial calcium homeostasis[1][6]. No approved drugs directly target SLC25A3, but it represents a potential therapeutic target for mitochondrial and metabolic diseases[1][6].
Other names
Solute carrier family 25 member 3SLC25A3Phosphate transport protein, mitochondrialPhosphate carrier (PHC)PiC2, PiCPTPOK/SW-cl.48
02
Mechanism of action
Not applicable for approved drugs, but research compounds indirectly modulate carrier activity, mitochondrial permeability, or metabolic flux through SLC25A3 in experimental models.
03
Biological functions
Phosphate transport into the mitochondrial matrix, which is essential for oxidative phosphorylation and ATP synthesisCopper transport (recent evidence shows SLC25A3 can also transport copper, impacting cytochrome c oxidase activity)Regulation of mitochondrial calcium handlingModulation of mitochondrial permeability transition pore (MPTP) activity (implicated in cell death pathways; not a direct pore component but a regulator)
04
Disease associations
Mitochondrial phosphate carrier deficiency (a fatal disorder in children; characterized by lactic acidosis, hypertrophic cardiomyopathy, hypotonia)Cardiomyopathy (congenital or acquired form, especially hypertrophic cardiomyopathy)Muscle hypotoniaLactic acidosis (in the context of metabolic/energy deficiencies)Other (broad mitochondrial dysfunctions; some evidence implicates roles in apoptosis susceptibility in certain settings)
05
Safety considerations
Loss-of-function mutations are associated with fatal infantile disease, severe lactic acidosis, cardiomyopathy, and myopathyTargeting could impact fundamental energy metabolism, leading to cardiac, muscular, and neurological side effectsPotential for mitochondrial toxicity if transporter function is impaired
06
Interacting drugs
Currently, no specific approved drugs directly target SLC25A3 in therapy, but small molecules like bongkrekic acid and analogs are used experimentally to investigate function and conformation in the ADP/ATP carrier, another SLC25 member. No direct clinical use established for SLC25A3-specific ligands.
07
Biomarkers
SLC25A3 gene mutations serve as biomarkers for mitochondrial phosphate carrier deficiency and cardiomyopathyAltered SLC25A3 expression or function could be explored as a biomarker for mitochondrial disease diagnostics and perhaps for assessing certain metabolic syndromes
Beyond the preview
Go deeper on Phosphate carrier protein, mitochondrial (SLC25A3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phosphate carrier protein, mitochondrial (SLC25A3).